まとめ
低用量のヘパリン予防療法により,大手術後の静脈栓塞が著しく減少しました. 軽度の出血がわずかに増加した一方で,治療は良好に耐えており,深静脈血栓症の予防に効果的でした.
科学分野:
- 血管外科 血管外科
- トロンボプロフィラキシー
- 薬理学 薬理学とは
背景:
- 静脈血栓塞栓症 (VTE) は,メジャー選択手術後の重大なリスクです.
- 効果的な予防戦略は,VTEの発生率と関連する罹患率を減らすために不可欠です.
- 低用量ヘパリンは予防薬として研究されているが,その正確な影響については継続的な評価が必要である.
研究 の 目的:
- 大手選択手術後の静脈栓塞 (VT) を予防する低用量ヘパリン予防の有効性を評価する.
- 低用量ヘパリン予防と関連した出血合併症の発生率を評価する.
- この予防療法療法の全体的な安全性と耐受性を決定するために.
主な方法:
- 大手選択外科手術を受けた820人の患者を対象とした前向きな対照試験.
- 放射性ヨウ素 (125I) で標識されたフィブリノゲンによる足のスキャンを使用して静脈栓塞の検出.
- ヘパリン治療群と対照群のVTE発生率と出血イベントの比較.
主要な成果:
- VTの総発生率は,対照群の16.0%からヘパリン治療を受けた患者の4.2%に減少した.
- ポプリテス静脈または股関節静脈血栓症の発生率は2.9%から1.0%に減少しました.
- 軽度の出血 (傷の血腫,輸血量,血球値の低下) のわずかな増加が観察されましたが,臨床的には無意味でした.
結論:
- 低用量のヘパリン予防は,メジャー選択手術後の静脈血栓の減少に非常に効果的です.
- 観察された出血合併症の増加は軽微であり,VTE予防の利点を上回らなかった.
- ヘパリン予防はよく耐えており,この患者集団におけるVTE予防のための安全で有益な戦略です.
関連する概念動画
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...


